Publication date: 
Tue., Jan. 22, 2019 2:00pm EST ·

FDA Prepares Naloxone for OTC Status

The FDA has developed two consumer-friendly model Drug Facts Labels (DFLs) for over-the-counter (OTC) naloxone, a drug used to treat opioid overdose — one for use with a nasal spray and one for use with an auto-injector. These model labels contain information that a consumer needs to administer naloxone safely and effectively. With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, FDA notes it is critical to enable new ways to increase availability of naloxone, such as informed OTC access.

Publication date: 
Thu., Jan. 10, 2019 2:00pm EST ·

A Dose of Caution

Grandparents can help protect kids from medication-related poisonings — National Safety Council.

Pages